Association of angiotensin converting enzyme gene insertion/deletion polymorphism with lung cancer in turkey

Cancer Genetics and Cytogenetics

Volumn 198, Issue 1, 2010, Pages 22-26

  Nacak, Muradiye ^a,b   Nacak, Ibrahim ^c   ŞanlŞ, Maruf ^a   Özkur, Mehtap ^a   Pektaş, Mehtap ^b   Aynacioĝlu, A Şükrü ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b MERSIN UNIVERSITY   (Turkey)

^c Sani Konukoglu Medical Center   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GENOMIC DNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; TURKEY (REPUBLIC); CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS; SEQUENCE DELETION; TURKEY;

EID: 77950348823     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.11.019     Document Type: Article

References (48)

1. Karlikaya C., Cakir E.E. Lung cancer histopathology in the Thrace region of Turkey and comparison with national data. Tuberk Toraks 2005, 53:132-138.
2. Goksel T., Akkoclu A. Pattern of lung cancer in Turkey, 1994-1998. Respiration 2002, 69:207-210.
3. Liu G., Zhou W., Christiani D.C. Molecular epidemiology of non-small cell lung cancer. Semin Respir Crit Care Med 2005, 26:265-272.
4. Yang M., Choi Y., Hwangbo B., Lee J.S. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer 2007, 57:135-142.
5. Park J.M., Choi J.E., Chae M.H., Lee W.K., Cha S.I., Son J.W., Kim C.H., Kam S., Kang Y.M., Jung T.H., Park J.Y. Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study. BMC Cancer 2006, 6:70.
6. Kang H.G., Chae M.H., Park J.M., Kim E.J., Park J.H., Kam S., Cha S.I., Kim C.H., Park R.W., Park S.H., Kim Y.L., Kim I.S., Jung T.H., Park J.Y. Polymorphisms in TGF-beta1 gene and the risk of lung cancer. Lung Cancer 2006, 52:1-7.
7. Scholzen T.E., Stander S., Riemann H., Brzoska T., Luger A.L. Modulation of cutaneous inflamation by converting enzyme. J Immunol 2003, 170:3866-3873.
8. Costerousse O., Jaspard E., Allegrini J., Wei L., Alhenc-Gelas F. Angiotensin converting enzyme (kininase II). Molecular and physiological aspects. C R Seances Soc Biol Fil 1992, 186:586-598.
9. Kaufman K.M., Kelly J., Gray-McGuire C., Asundi N., Yu H., Reid J., Baird T., Hutchings D., Bruner G., Scofield R.H., Moser K., Harley J.B. Linkage analysis of angiotensin-converting enzyme(ACE) insertion/deletion polymorphism and systemic lupus erythematosus. Mol Cell Endocrinol 2001, 177:81-85.
10. Hubert C., Houot A.M., Corvol P., Soubrier F. Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem 1991, 266:15377-15383.
11. Jeunemaitre X., Lifton R.P., Hunt S.C., Williams R.R., Lalouel J.M. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nature Genet 1992, 1:72-75.
12. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86:1343-1346.
13. Tiret L., Rigat B., Visvikis S., Breda C., Corvol P., Cambien F., Soubrier F. Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992, 51:197-205.
14. Papadopoulos K.I., Melander O., Orho-Melander M., Groop L.C., Carlsson M., Hallengren B. Angiotensin converting enzyme (ACE) gene polymorphism in sarcoidosis in relation to associated autoimmune diseases. J Intern Med 2000, 247:71-77.
15. Uçar G., Yildirim Z., Ataol E., Erdoĝan Y., Biber C. Serum angiotensin converting enzyme activity in pulmonary diseases: correlation with lung function parameters. Life Sci 1997, 61:1075-1082.
16. Calabro S., Arcangeli G., Cisno F., Altinier G., Giuliano G. The evaluation of serum angiotensinconverting enzyme in silicosis and silicotuberculosis. Med Lav 1990, 81:283-289.
17. Ouellette D.R., Kelly J.W., Anders G.T. Serum angiotensin-converting enzyme level is elevated in patients with human immunodeficiency virus infection. Arch Intern Med 1992, 152:321-324.
18. Migdalis I.N., Iliopoulou V., Kalogeropoulou K., Koutoulidis K., Samartzis M. Elevated serum levels of angiotensin-converting enzyme in patients with diabetic retinopathy. South Med J 1990, 83:425-427.
19. Lauta V.M. ACE: physiopathology and role in the diagnosis and prognosis of systemic granulomatosis, neoplasms and lung toxicity caused by antineoplastic agents. Recenti Prog Med 1990, 81:601-613.
20. Schweisfurth H., Heinrich J., Brugger E., Steinl C., Maiwald L. The value of angiotensin-I-converting enzyme determinations in malignant and other diseases. Clin Physiol Biochem 1985, 3:184-192.
21. Procházka J., Krepela E., Sedo A., Viklický J., Fiala P. Aminopeptidases and angiotensin I-converting enzyme activities in primary human lung tumors and lung parenchyma. Neoplasma 1991, 38:501-508.
22. Bakan N., Bakan E., Süerdem M., Yiĝitoĝlu M.R. Serum zinc and angiotensin-converting enzyme levels in patients with lung cancer. Biofactors 1988, 1:177-178.
23. Bunn P.A., Chan D.C., Dienhart D.G., Tolly R., Togawa M., Jewett P.B. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines. Cancer Res 1991, 52:24-31.
24. Chan D., Gera L., Stewart J., Helfrich B., Verella-Garcia M., Johnson G., Baron A., Yang J., Puck T., Bunn P.A. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines by a " biased agonist" mechanism. Proc Natl Acad Sci 2002, 99:4608-4613.
25. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extraction DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
26. Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase1). Nucleic Acids Res 1992, 20:1433.
27. Xu H., Spitz M.R., Amos C.I., Shete S. Complex segregation analysis reveals a multigene model for lung cancer. Hum Genet 2005, 116:121-127.
28. Amos C.I., Caporaso N.E., Weston A. Host factors in lung cancer risk: a review of interdisciplinary studies. Cancer Epidemiol Biomarkers Prev 1992, 1:505-513.
29. Heffelfinger S.C. The renin angiotensin system in the regulation of angiogenesis. Curr Pharm Des 2007, 13:1215-1229.
30. Stewart J.M., Gera L., Chan D.C., York E.J., Stewart L.T., Simkeviciene V., Helfrich B. New lung cancer drugs from bradykinin antagonists. Chest 2004, 125:148S.
31. Stewart J.M. Bradykinin antagonists as anti-cancer agents. Curr Pharm Des 2003, 9:2036-2042.
32. Danser A.H., Schalekamp M.A., Bax W.A., van den Brink A.M., Saxena P.R., Riegger G.A., Schunkert H. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995, 92:1387-1388.
33. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J.P., Arveiler D., Luc G., Bard J.M., Bara L., Ricard S. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992, 359:641-644.
34. Raynolds M.V., Bristow M.R., Bush E.W., Abraham W.T., Lowes B.D., Zisman L.S., Taft C.S., Perryman M.B., Perryman M.B. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993, 342:1073-1075.
35. Schunkert H., Hense H.W., Holmer S.R., Stender M., Perz S., Keil U., Lorell B.H., Rieggger G.A. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994, 330:1634-1638.
36. Sharma P., Carter N.D., Barley J., Brown M.M. Molecular approach to assessing the genetic risk of cerebral infarction: deletion polymorphism in the gene encoding angiotensin 1-converting enzyme. J Hum Hypertens 1994, 8:645-648.
37. Morris B.J., Zee R.Y., Schrader A.P. Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals. J Clin Invest 1994, 94:1085-1089.
38. Ozkur M., Erbagci Z., Nacak M., Tuncel A.A., Alasehirli B., Aynaci{dotless}oglu A.S. Association of insertion deletion polymorphism of the angiotensin-converting enzyme gene with psoriasis. Brit J Dermatol 2004, 151:792-795.
39. Shim Y.H., Kim H.S., Sohn S., Hon Y.M. Insertion/deletion polymorphism of angiotensin converting enzyme gene in Kawasaki disease. J Korean Med Sci 2006, 21:208-211.
40. Hong S.J., Yang H.I., Yoo M.C., In C.S., Yim S.V., Jin S.Y., Choe B.K., Chung J.H. Angiotensin converting enzyme gene polymorphism in Korean patients with primary knee osteoarthritis. Exp Mol Med 2003, 35:189-195.
41. Uhm W.S., Lee H.S., Chung Y.H., Kim T.H., Bae S.C., Joo K.B., Kim T.Y., Yoo D.H. Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE. Lupus 2002, 11:227-233.
42. Rice G.I., Foy C.A., Grant P.J. Angiotensin converting enzyme and angiotensin II type 1-receptor gene polymorphisms and risk of ischaemic heart disease. Cardiovasc Res 1999, 41:746-753.
43. Cheon K.T., Choi K.H., Lee H.B., Park S.K., Rhee Y.K., Lee Y.C. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer. Lung 2000, 178:351-360.
44. Uemura H., Ishiguro H., Nakaigawa N., Nagashima Y., Miyoshi Y., Fujinami K., Sakaguchi A., Kubota Y. Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor. Mol Cancer Ther 2003, 2:1139-1147.
45. Fujita M., Hayashi I., Yamashina S., Fukamizu A., Itoman M., Majima M. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis 2005, 26:271-279.
46. Lever A.F., Hole D.J., Gillis C.R., McCallum I.R., McInnes G.T., MacKinnon P.L., Meredith P.A., Murray L.S., Reid J.L., Robertson J.W. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?. Lancet 1998, 352:179-184.
47. Fryzek J.P., Poulsen A.H., Lipworth L., Pedersen L., Norgaard M., Mc Laughlin J.K., Friis S. A cohort study of antihypertensive medication use and breast cancer among Danish women. Breast Cancer Res Treat 2006, 97:231-236.
48. Van der Knaap R., Siemes C., Coebergh J.W., van Duijn C.M., Hofman A., Stricker B.H. Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study. Cancer 2008, 15(112):748-757.